MARVELD2 and Huntington disease: In Huntington’s disease, TRiC/CCT plays critical roles in buffering the toxicity of mutant huntingtin (mHTT), with evidence showing that TRiC can bind and stabilize mHTT to prevent its conversion into toxic oligomers and aggregates (Tam et al., 2006).